The newly added Left Ventricular Assist Device market research report by Value Market Research disclose all the important information associated with the market such as value, growth factor, trends, market share, size, and challenges for the forecasted timeline 2020-2028. Further, this report also highlights smart strategy adopted by major players and also their market share. Basically, this report is designed to give a proper understanding of industry structure and competition intensity attractiveness.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Left Ventricular Assist Device market include AbioMed, Berlin Heart, Abbott (Thoratec), ReliantHeart, and Medtronic (HeartWare). This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
Get more information on "Global Left Ventricular Assist Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-ventricular-assist-device-market/download-sample
Market Dynamics
Heart failure is a major cause of death with prevalence estimated at 6.5 million adults, the prevalence will rise with the ageing of the population. This is anticipated to drive the growth of the market during the forecast period. Increasing life expectancy, healthcare spending, significant advancements in healthcare management as well as medical technology with arrivals of newer generation devices have improved patient outcomes, leading to the increasing use of LVAD. Left ventricular assist device is emerging as a durable and safe therapy for end-stage into the heart failure paradigm. However, the burden of adverse events remained the major restraining factor for the market in the current state of ventricular assist device therapy. Ongoing investigation and implication of future improvement in the device may eradicate this drawback.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of Left Ventricular Assist Device.
Browse Global Left Ventricular Assist Device Market Research Report with detailed TOC at https://www.valuemarketresearch.com/report/left-ventricular-assist-device-market
Market Segmentation
The entire Left Ventricular Assist Device market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Type
· BTT Therapy
· Destination Therapy (DT)
· Other
By Application
· Hospitals
· Clinics
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Left Ventricular Assist Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Purchase Complete Global Left Ventricular Assist Device Market Research Report at https://www.valuemarketresearch.com/contact/left-ventricular-assist-device-market/buy-now
About Us:
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information.
We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com
Market Size – USD 1.06 Billion in 2018, Market Growth - CAGR of 11.3%, Market Trends –Technological advancements in the healthcare sector.
The Global Left ventricular assist device (LVAD) Market is forecast to reach USD 2.32 Billion by 2026, according to a new report by Reports and Data.Various factors drive the growth of the LVAD market.
With such a rise in the rate of obesity, there has been an increase in the demand for cardiovascular care, which in turn has resulted in promoting the LVAD market.
The report also aims to benefit the user by providing constructive data to gain insight into the market growth, size, and investment approaches.The key companies profiled in the market are: Sunshine Heart, CorWave, Apaxis Inc., Sun Medical Technology Research, Evaheart, Abiomed, HeartWare International, Jarvik Heart, HeartWare International, Reliantheart, Transonic, Thoratec, Terumo.Further key findings from the report suggestThe Left ventricular assist device (LVAD) market held a market share of USD 1.06 Billion in the year 2018 and is forecasted to witness a CAGR of 11.3% during the forecast period.Changing lifestyle, rise in geriatric population, and increased investment in the healthcare sector are some of the factors that have resulted in boosting the growth of the market.In context to type, Implantable LVAD can be seen to occupy the largest market share.
The fact that this type of pump is associated with features like long durability, simple placement process through surgery and minimal risk of thrombosis as compared to other types of pump have resulted in this segment to generate the highest revenue.In the application segment, Bridge-to-Recovery (BTR) Therapy can be seen to occupy the largest market share that generated the highest revenue of USD 0.35 Billion in 2018 with a CAGR of 12.1% during the forecast period.
Factors like high occurrence rate of cardiovascular disease, availability of advanced technology, and rise in the geriatric population have contributed to the market share of this region.Type Outlook (Revenue, USD Billion; 2016-2026)Transcutaneous LVADImplantable LVADAge group Type Outlook (Revenue, USD Billion; 2016-2026)20-39 years40-59 years60-79 yearsPump type Outlook (Revenue, USD Billion; 2016-2026)Pulsatile volume-displacement pumpsFirst-Generation DevicesAxial flow pumpsSecond-Generation DevicesContinuous flow centrifugal pumpsThird-Generation DevicesApplication Type Outlook (Revenue, USD Billion; 2016-2026)Bridge-to-Recovery (BTR) TherapyBridge-to-Transplant (BTT) TherapyDestination TherapyBridge-to-Candidacy (BTC) TherapyEnd-user Outlook (Revenue, USD Billion; 2016-2026)Cardiology CentersHospitalsBrowse Complete Report “Left Ventricular Assist Device (LVAD) Market” @ https://www.reportsanddata.com/report-detail/left-ventricular-assist-device-lvad-marketThe report further segments the market on the basis of key regions of the world and offers an assessment of the production and manufacturing capacity, import and export, production and consumption patterns, supply and demand ratio, and the presence of key players in each region.
The global ventricular assist device market size is expected to reach USD 4.1 billion by 2027, according to a new report by Radiant Insights, Inc., registering a CAGR of 11.7% over the forecast period.
Increase in prevalence of cardiovascular diseases such as congenital heart diseases, heart failure, hypertension, ventricular septal defect, and stroke due to rise in adoption of unhealthy lifestyle habits such as physical inactivity, smoking, and alcohol consumption drives the demand for ventricular assist devices (VADs).
According to estimates published by the United Nations in 2012, the global geriatric population was nearly 809.4 million and is expected to witness a twofold increase by 2050 with an estimated population of over 2,000 million.
Geriatric population has a high risk of various cardiovascular diseases and a majority of them are expected to suffer from heart failure or stroke.
For instance, the United Kingdom National Health Service (UK NHS) financed a bridge-to-transplant (BTT) program in which left ventricular assist devices (LVADs) such as HeartMate II and HeartWare are used for treating patients.
The increasing patient pool for cardiovascular disorders, coupled with growing demand for mechanical assist devices, is expected to drive the demand for VADs over the forecast period.
